ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,755.76
1.56%
Dow Jones
42,528.65
1.29%
US Dollar vs MXN
20.1095
-0.53%
Brent Oil
72.515
0.93%
Bitcoin
88,123.42
2.39%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Australia
  5. ASX

  6. Cyclopharm Limited (CYC) Cotización

Cyclopharm Limited

Cyclopharm Limited (CYC)

Jardine Cycle and Carriage Ltd
1.24
-0.14
(-10.14%)
Cerrado 24 Marzo 11:00PM
Delayed by 20 minutes
Gráfico avanzado
Rendering Error

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
1.24
Postura de Compra
1.22
Postura de Venta
1.38
Volume Operado de la Acción
388,443
1.185 Rango del Día 1.38
1.185 Rango de 52 semanas 2.50
Capitalización de Mercado [m]
116.795M
Precio Anterior
1.38
Precio de Apertura
1.38
Hora
215
@
1.23
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
138,342
Acciones en circulación
94,189,769
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-8.85
Beneficio por acción (BPA)
-0.14
turnover
27.58M
Beneficio neto
-13.2M

Acerca de Cyclopharm Limited

Sector
Electromedical Apparatus
Industria
Electromedical Apparatus
Sitio web
www.cyclopharm.com
Sede
Sydney, New South Wales, Aus
Fundado
-
Cyclopharm Limited is listed in the Electromedical Apparatus sector of the Australian Stock Exchange with ticker CYC. The last closing price for Cyclopharm was AUD1.38. Over the last year, Cyclopharm shares have traded in a share price range of AUD 1.185 to AUD 2.50.

Cyclopharm currently has 94,189,769 shares in issue. The market capitalisation of Cyclopharm is AUD129.98 million. Cyclopharm has a price to earnings ratio (PE ratio) of -8.85.

CYC Últimas noticias

Más noticias
No hay noticias para mostrar aún.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.25-16.77852348991.491.491.185452151.40728778DE
4-0.69-35.75129533681.931.931.1851268081.4518211DE
12-0.31-201.552.51.1851383421.92140277DE
26-0.2-13.88888888891.442.51.185780221.86500162DE
52-0.56-31.11111111111.82.51.185641481.76773811DE
156-0.4-24.39024390241.643.150.95343041.82981445DE
2600.567.56756756760.743.450.72331911.90551669DE

CYC - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cyclopharm?
El precio actual de las acciones de Cyclopharm es AUD 1.24
¿Cuántas acciones de Cyclopharm están en circulación?
Cyclopharm tiene 94,189,769 acciones en circulación
¿Cuál es la capitalización de mercado de Cyclopharm?
La capitalización de mercado de Cyclopharm es AUD 129.98M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cyclopharm?
Cyclopharm ha negociado en un rango de AUD 1.185 a AUD 2.50 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Cyclopharm?
El ratio precio/beneficio de Cyclopharm es -8.85
¿Cuál es el ratio de efectivo a ventas de Cyclopharm?
El ratio de efectivo a ventas de Cyclopharm es 4.23
¿Cuál es la moneda de reporte de Cyclopharm?
Cyclopharm presenta sus resultados financieros en AUD
¿Cuál es el último ingresos anual de Cyclopharm?
El último ingresos anual de Cyclopharm es AUD 27.58M
¿Cuál es el último beneficio anual de Cyclopharm?
El último beneficio anual de Cyclopharm es AUD -13.2M
¿Cuál es la dirección registrada de Cyclopharm?
La dirección registrada de Cyclopharm es UNIT 4, 1 THE CRESCENT KINGSGROVE, SYDNEY, NEW SOUTH WALES, 2208
¿Cuál es la dirección del sitio web de Cyclopharm?
La dirección del sitio web de Cyclopharm es www.cyclopharm.com
¿En qué sector industrial opera Cyclopharm?
Cyclopharm opera en el sector ELECTROMEDICAL APPARATUS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ERWErrawarra Resources Ltd
AUD 0.056
(115.38%)
4.73M
SMNOAStructural Monitoring Systems PLC
AUD 0.10
(63.93%)
35.81k
NRXONoronex Limited
AUD 0.008
(60.00%)
550k
GGEGrand Gulf Energy Limited
AUD 0.0015
(50.00%)
47k
MEMNusep Ltd
AUD 0.01
(42.86%)
52.21M
OM1Omnia Metals Group Ltd
AUD 0.0095
(-87.82%)
6.73M
TMSOTennant Minerals Ltd
AUD 0.001
(-50.00%)
3.69M
ACROAcrux Ltd
AUD 0.001
(-50.00%)
1.43M
EUROBEuropean Lithium Limited
AUD 0.001
(-50.00%)
6.06M
EDEEden Innovations Ltd
AUD 0.001
(-50.00%)
300k
MEMNusep Ltd
AUD 0.01
(42.86%)
52.21M
SIGSigma Healthcare Limited
AUD 2.80
(-0.71%)
37.81M
VAUVault Minerals Ltd
AUD 0.445
(-3.26%)
37.24M
WOAWide Open Agriculture Ltd
AUD 0.019
(-9.52%)
32.2M
SYASayona Mining Limited
AUD 0.0185
(-7.50%)
31.74M

CYC Finanzas

Finanzas
Rendering Error

Discusión

Ver feed completo
manibiotech manibiotech 2 minutos hace
It has zero merit and zero evidence
NWBO
CommodityCoverage CommodityCoverage 2 minutos hace
A junior miner quietly ramping up production, launching fresh exploration, and eyeing a 66% upside? Luca Mining (LUCA.v LUCMF) just scored a BUY rating and a $1.90 target from Couloir Capital—here’s why this could be one of the most under-the-radar growth plays in Mexico right now: https://x.com/Stc
LUCMF
JTORENCE JTORENCE 3 minutos hace
And the beat still goes on without so much as a blink of her eye.
NWBO
al44 al44 3 minutos hace
All we need is Joe, Joe is all we need?

By Silvio Canto, Jr.


Memo to Mr. Biden: A big reason for the condition that the party is in is because of your policies.

Does President Trump understand how lucky he is with respect to his enemies? He proba
mike_dotcom mike_dotcom 3 minutos hace
Management in this company is deeply mistrusted by the street. That's evident in the share price. Just last week they spoke of imminent revenues and how they are going to handle distribution and look what that is doing to the share price. Nobody believes a single word they say - other than the WG
AVXL
surfer44 surfer44 3 minutos hace
Alice Cooper - No More Mr. Nice Guy (from Alice Cooper: Trashes The World)

https://youtu.be/KN6ngThqMEs
novinut novinut 3 minutos hace
Everyone has equal motivation to post.


Then why do you have as many posts as almost everyone else combined?
oldstocks oldstocks 3 minutos hace
Tj can you answer this question?
Some of us own so much of AFFU that it would not take much for us to end up owning 5% or more of AFFU
Which leads to the question since Affluence Corp is not a SEC filer and Affluence Corp is an Alternative reporting company do we file Schedule 13D or i
AFFU
makinezmoney makinezmoney 4 minutos hace
$LOT: Used to be LOTUS Luxury Cars...........


https://www.dimsumdaily.hk/lotus-tech-ceo-optimistic-about-growth-prospects-in-chinas-luxury-nev-market/


GO $LOT
LOT
johnnytrader33 johnnytrader33 4 minutos hace
then you have this pos idiot posting pure lies and FRAUD on stocktwits.

https://stocktwits.com/TradersTrader/message/608906189
TSOI
JonDoe1 JonDoe1 4 minutos hace
Congratulations you dug up the PR from January. Look how much HASN'T been accomplished. Also if you look at their estimated net revenue it equates to less than a penny per share. Their estimate is bound to be inflated also as usual.
AABB
Almosthere Almosthere 4 minutos hace
I don’t think we are even near peaking. Just the tip of the iceberg.

West coast is just waking up.
LQMT
investingnotgambling investingnotgambling 4 minutos hace
Wish I would’ve been paying attention. Lucky whoever got those .0109s.

🇺🇸🦅😎
ZHUD
redspinelpinktopaz redspinelpinktopaz 4 minutos hace
My thought is: it is not relevant to what we need
LWLG
martyDg martyDg 4 minutos hace
Keep pushing the regulator waiting for EDEN narrative!
NWBO
Monksdream Monksdream 4 minutos hace
MLGO over $7 the old fart scores big time
All you need is one a day
MLGO
amelia43 amelia43 4 minutos hace
Hm, I’d thought we’d be up much higher with all the phenomenal news.

Anyhow, Freddie is more than a buck below Fannie. Is it still worth buying Freddie?
FNMA
work-n-hard work-n-hard 5 minutos hace
Been sitting on this one a few weeks.
WIMI
JJ8 JJ8 5 minutos hace
Ascending Triple Top Breakout on 24-Mar-2025. GLTA
AMD
StayHumble StayHumble 5 minutos hace
$UBQU "no reverse split plans💹solid InnovativeOutcomes Merger"✅
https://x.com/CorporateUbqu/status/1765510100628726105?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1765510100628726105%7Ctwgr%5Ee557eba02d735a21ca28cca2ce7e12b746d613ff%7Ctwcon%5Es1_c10&ref_url=https%3A%2F
UBQU
TooFrank TooFrank 5 minutos hace
This is interesting… profitable Q4 accounting?

"We have expensed all research and development costs in the reporting periods and not capitalized them, which makes our accumulated losses appear higher and our assets appear lower."

This lays a good foundation for achievin
NIO
Paulie Pennies Paulie Pennies 5 minutos hace
$EVCO Authorized Shares 200,000,000 Outstanding Shares 8,371,391 😎

EVCO
Value_Investor Value_Investor 5 minutos hace
VTXB is the BEST Investment-Grade Super-Undervalued Hyper-Oversold NEVER-R/S Frequently-Paying-Cash-Dividend Fully-Reporting Current-Information -tier OTC stock among Over Ten Thousands Of Peers!

However, the company Must PAUSE or STOP the dilution sale for NINE ~ TEN Months just
VTXB
al44 al44 6 minutos hace
Live by the Autopen, Die by the Autopen

By Brian C. Joondeph

Autopen has been in the news these past few weeks. It’s not a new alternative rock group; rather, it’s a shadow government, worse than anything in a Robert Ludlum novel, governing America behind the scenes wit

Su Consulta Reciente

ASX
CYC
Cyclopharm
Delayed Upgrade Clock
ADVFN Logo
México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios